Pyxis Oncology Inc expected to post a loss of 25 cents a share - Earnings Preview
09/05/2024 12:25
* Pyxis Oncology Inc PYXS.OQ PYXS.O is expected to show
a rise
in quarterly revenue when it reports results on May 11
(estimated) for the period ending March 31 2024
* The Boston Massachusetts-based company is expected to
report
revenue of $4.125 million, according to the mean estimate from 4
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Pyxis Oncology Inc is
for a
loss of 25 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.
* Wall Street's median 12-month price target for Pyxis
Oncology
Inc is $8.50, above its last closing price of $4.27.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jan. 1 0001 -0.48 -0.47 -0.33 Beat 30.5
Sep. 30 0001 -0.49 -0.51 -0.56 Missed -10.5
Jun. 30 2023 -0.64 -0.65 -0.41 Beat 36.7
Mar. 31 2023 -0.90 -0.90 -0.55 Beat 38.8
Dec. -0.93 -1.01 Missed -8.7
31 2022
Sep. 30 2022 -0.81 -0.81 -0.85 Missed -4.5
Jun. 30 2022 -0.75 -0.76 -0.79 Missed -3.7
Mar. 31 2022 -0.61 -0.61 -0.97 Missed -59.1
This summary was machine generated May 9 at 11:24 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)